Volume 17, Issue 3, November 2006
The Nurse Practitioner SIG Newsletter is underwritten through a grant from Amgen Inc.
Coordinator’s Message
Join Us at the ONS Advanced Practice Nursing Conference

Wendy Vogel, MSN, FNP, AOCNP
Kingsport, TN

Hello, SIG members! As the fall leaves change colors, I hope this finds you taking time for yourself to relax and admire the colors.

As the cochair of the Advanced Practice Nursing Conference, I would like to extend a personal invitation for you to attend! The conference is going to be one of the most exciting offerings for oncology advanced practice nurses (APNs) in the United States. We have wonderful speakers with very interesting topics, so check it out at www.ons.org/meetings/apn06/index.shtml. We will be having an informal SIG networking meeting on Friday, November 10, from noon-1:30 pm. Please join us!

As the doctorate of nursing practice (DNP) issue continues to whirl around us like the fall leaves, the Nurse Practitioner (NP) SIG will continue to try to keep you informed about the latest news. Check out the DNP podcast offered by ONS at http://onsopcontent.ons.org/meetings/podcasts.

The ONS News Instant Poll question in June was: “Are you in favor of the new doctor of nursing practice degree?” At poll closure, 471 people responded. Seventy percent were not in favor (n = 329), and 30% were in favor (n = 142). Another opinion poll on this topic, sponsored by Advance for Nurse Practitioners Newsletter, is located at http://nurse-practitioners.advanceweb.com/main.aspx. This is another opportunity to make your opinions known.

In scanning the latest information falling from the medical and nursing literature, I came across an interesting article by Chase and Pruitt (2006), published in the Journal of Nursing Education (Vol. 45, pp. 155-161), titled “The Practice Doctorate: Innovation or Disruption?” Issues regarding nursing faculty shortages, cost of doctoral education, effects on academic nursing, titling and licensure and curricula are addressed. Proposed solutions also are discussed. One of the most profound and thought-provoking statements in the article was, “When will nursing celebrate its own strengths and not build programs patterned after other professions?” I think that all of you, regardless of where you stand, will find this article provocative.

At the end of June, Janet Fulton, PhD, RN, the Clinical Nurse Specialist (CNS) SIG coordinator, and I, along with the assistance of several other NPs and CNSs, sent a letter to the ONS Board of Directors detailing our concerns regarding the DNP and requesting the development and publication of a position paper against the requirement of the DNP as entry level into advanced practice nursing. This letter may be viewed at http://nursepractition.vc.ons.org/page/26617. The Board voted on the development of a position statement, and the motion was defeated. (The Board minutes are found at http://onsecomvo.ons.org) Our understanding is that the development of a position statement is not planned at this time. We were told that the Board is creating a “DNP Fact Sheet,” and I am sure that they would welcome your comments and suggestions as ONS members and as APNs. You may obtain Board members’ e-mail addresses at www.ons.org/about/onsboard.shtml. Many of you have sent various comments to me as the NP SIG coordinator, and I encourage you to share these with your elected Board members.

In August, I filmed a rebuttal to a recent MedGenMed editoral (www.medscape.com/viewarticle/528346) about the DNP proposal on Medscape, and it was aired on October 6. Some responses to the original article have been published already, including one by our own NP SIG member, Katen Moore, RN, MSN, APRN, BC, AOCN®. You may read these at www.medscape.com/viewarticle/543596?src=mp. I encourage you to send in your own responses.

We are involved in two crisp, new, and exciting projects right now. The Oncology NP brochure has been updated and sent to publishing. You soon will be able to purchase these for your practice. Members on this project team included Mary Pat Lynch, CRNP, MSN, AOCN®, and Catherine Franklin, RN, NP-C. A second project work group is developing an ONS publication called “So You Want to Be an Oncology Nurse Practitioner.” Heather Greene, RN, MSN, FNP, AOCNP, Kathy Sharp, RN, MSN, APRN-BC, AOCNP, Barb Biedrzycki, RN, MSN, AOCN®, CRNP, and Joyce Marrs, MS, APRN-BC, AOCNP, are participating on this project. If you have any ideas for a spicy SIG project, let me know!

I look forward to seeing you all at the APN conference. Until then, enjoy the golden warmth of this fall.

The Nurse Practitioner SIG Newsletter is produced by members of the
Nurse Practitioner SIG and ONS staff and is not a peer-reviewed publication.

Special Interest Group Newsletter  November 2006

Celebrate Nurse Practitioner Week on November 5-11

Celebrate with your oncology nurse practitioner colleagues and earn as many as 15 credit hours, including up to 3.4 pharmacology hours, at the ONS Advanced Practice Nursing Conference, November 9-11, 2006, in Pittsburgh, PA. Check out www.ons.org/meetings/apn06/index.shtml to learn more about this exciting conference.

Find even more ways to celebrate Nurse Practitioner Week in the American Academy of Nurse Practitioners’ resource guide that can be found at www.aanp.org/About+AANP/AANP+Information/NPWK06ResourceGuide.htm.
Back to SIG Newsletter front page

Special Interest Group Newsletter  November 2006

Excellent Opportunity
Nurse Practitioner SIG Has an Immediate Opening for the Virtual Community


As an administrator, you are responsible for

  • Updating your SIG’s calendar of events.
  • Posting your SIG’s announcements, meeting minutes, notes, and favorite Web site links.
Click here to review the Administrator’s Manual.

ONS Manager of Member Services Diane Scheuring, MBA, is available to help you through the process. Contact SIG Coordinator Wendy Vogel, MSN, FNP, AOCNP, at wvogel@charter.net or Diane at 412-859-6256 or dscheuring@ons.org for more details.
Back to SIG Newsletter front page

Special Interest Group Newsletter  November 2006

ONS Advanced Practice Nursing Conference Will Address Unique Needs of Nurse Practitioners and Clinical Nurse Specialists

Marilyn L. Haas, PhD, ANP-C
Asheville, NC

Deborah Rust, RN, MSN, CRNP, AOCN®
Pittsburgh, PA

What are some of the topics that will be presented?
As this year’s theme is “Partnership in Practice and Strength in Collaboration,” the planning team collaborated to select topics that are pertinent to nurse practitioners (NPs) and clinical nurse specialists (CNSs). Hot topics such as osteoporosis, sleep-wake disturbances, nutritional assessments, advanced geriatric assessments, and gastrointestinal carcinomas will be presented. Trends in breast cancer, brain tumors, and genetics and genomics of cancer will be included in the three-day conference. Mentorship and professional practice issues will be discussed in breakout sessions.

How were the topics selected for the conference?
Topic selection is the most in-depth part of the planning process. This year brought more challenges because CNSs were invited and the conference was renamed to reflect the inclusiveness. Therefore, the planning team wanted to be inclusive of relevant topics for NPs and CNSs. The team reviewed the evaluations from the previous conference and tried to incorporate all of the suggestions for potential topics. Second, the team selected topics that are hot and current issues, such as the doctorate of nursing practice and advocacy for advanced practice nurses (APNs).

What are the backgrounds of the planning committee members?
The committee members are from the NP and CNS SIGs and have a wealth of experience and knowledge. The team has six committee members (three NPs and three CNSs), with Kristine LeFebvre, MSN, RN, AOCN®, helping the team as the ONS project manager. Barbara Holmes Gobel, RN, MS, AOCN®, and Wendy Vogel, MSN, FRNP, AOCNP, are the team’s co-leaders. Following are the team members’ biographical information.

Barbara Holmes Gobel, RN, MS, AOCN®, is the oncology clinical nurse specialist at Northwestern Memorial Hospital in Chicago, IL. Her primary role responsibilities include advancing nursing practice through education with staff, patients, and physicians; consultation; research; and quality-improvement projects. Barbara served as the previous CNS SIG coordinator.

Wendy Vogel, MSN, FNP, AOCNP, is a board-certified oncology NP with Blue Ridge Medical Specialists in Bristol, Tennessee, where she has practiced for the past 12 years. As an NP, Wendy manages the care of patients who are undergoing chemotherapy, as well as patients who are at high risk for developing breast, colon, or ovarian cancer. She is also part of the clinical research team and functions as a subinvestigator. She is an adjunct faculty with the School of Nursing at Milligan College in Tennessee. Wendy serves as the current NP SIG coordinator.

Lynne Brophy, RN, MSN, AOCN®, is an oncology CNS at Bethesda North Hospital in Cincinnati, OH. She has published and lectured extensively in the areas of biotherapy, immune system function and dysfunction, breast cancer, integration of evidence into practice and basic oncology nursing. She has done research in the areas of pain knowledge, brachytherapy using the MammoSite® (Cytyc Corporation, Palo Alto, CA) catheter and lung cancer prevention. She has spent the majority of her career in community and home health settings. She hopes to bring the perspective of the nurse caring for people in a community setting to her work as an APN workshop planning committee member.

Marilyn Haas, PhD, CNS, ANP-C, is a certified adult NP at Mountain Radiation Oncology in Asheville, NC, where she has practiced for the past 10 years. Marilyn’s primary role is symptom management of patients undergoing radiation therapy, but she also participates in consults and follow-up visits. Marilyn serves as an auxiliary faculty member in the School of Nursing at Duke University in Durham, NC. She served as the previous Radiation SIG coordinator.

Marcelle Kaplan, RN, MS, OCN, AOCN®,
has been the breast oncology clinical nurse specialist at New York-Presbyterian Hospital, Weill Cornell Medical Center, in New York City, for the past 10 years. In this position, Marcelle has a wide-ranging educational role teaching and supporting patients pre- and post-surgery, giving outreach presentations, and facilitating a support group. She is a member of the institutional review board for Weill Medical College at Cornell University. Also, she has been appointed as the first nurse member of the Board of Advisors for the American Cancer Society’s Manhattan region. Marcelle serves on the review board of the Clinical Journal of Oncology Nursing. She is a past-president of the Oncology Nursing Certification Corporation and past-chair of the ONS Nominating Committee.

Deborah Rust, RN, MSN, CRNP, AOCN®, is currently the East Region clinical coordinator for Genentech BioOncology. During Deborah’s 21 years of oncology experience, she has spent 10 years as a clinical nurse specialist and 11 as a nurse practitioner. She also has work experience in academic and community cancer centers. She has served on numerous oncology-focused boards. In her local ONS chapter, she has been the program chair, director-at-large, and treasurer; on a national level, she was an Oncology Nursing Forum associate editor, continuing education provider reviewer, Publishing Council member, and volunteer for the Leukemia and Lymphoma Society.

What is the difference in the target audience for this year’s conference?
Beginning in 2006, oncology APNs will have the opportunity to convene an annual Advanced Practice Nursing Conference that will meet the educational goals of CNSs and NPs. This unique conference will address common educational needs while recognizing their separate needs through CNS and NP tracks. The ONS Steering Council received a request from the CNS SIG to develop a national conference for oncology CNSs. The council recommended to the ONS Board of Directors that the scope of the NP Conference be broadened to include specialized tracks for CNSs and NPs. With this decision, ONS created the current conference to be flexible to adapt to the needs of all APNs as the practice roles of both the CNS and NP evolve.
What are some the collaborative issues that impact both NP and CNS roles?
Both roles are needed and address different system needs. Each role has been shaped by population needs as well as educational, market, and legal forces that have varied over time. The different preparations of CNSs and NPs lead to different outcomes and purposes. Most importantly, the healthcare needs of the public are addressed and must be met through responsive, sensitive, and nursing practice. APNs offer much to the future; the present is not served by continuing to blur necessary role distinctions of NPs and CNSs.

What is the difference between the NP and CNS role?
The CNS role, which is primarily hospital based, has been restructured and has found new niches. CNSs in hospital niches have become responsible for aggregate care, which includes patient populations. CNSs are being asked to case manage, review utilization patterns, identify and correct systems problems, and establish large-scale organizational quality control. CNSs have not always been systematically prepared for these roles and have needed to acquire skill sets to be the driving forces of health economics. Mastering the underlying health policy, epidemiology, and population orientation facilitates an understanding of the associated resources and market gaps.

The NP role is directly accountable for accurate diagnosis and management of patients’ healthcare outcomes throughout the continuum of cancer care. The ability to efficiently diagnosis and manage care requires a broad based knowledge of common acute and chronic health conditions along with knowledge of risk and primary, secondary and tertiary prevention. NPs must ensure appropriate care for problems with management methods adapted sensitively to the individual patients, their families, and the community at large.

Conference will address unique needs of nurse practitioners and clinical nurse specialists. (2005, December). ONS News, 20, 11.

Grunder, T. (2003, October). CNS or NP debate: The need for a blended advanced practice nursing role. Kansas Nurse. Retreived September 5, 2006, from http://www.findarticles.com/p/articles/mi_qa3940/is_200310/ai_n9318860
Back to SIG Newsletter front page

Special Interest Group Newsletter  November 2006

Letters to the Editor

The previous issue of the Nurse Practitioner (NP) SIG newsletter was devoted to the doctorate of nursing practice. In it, NP SIG members expressed their thoughts on the novel degree and the issues surrounding the proposed mandatory entry level for NPs. Click here to read the opinions of your NP SIG colleagues.
Back to SIG Newsletter front page

Special Interest Group Newsletter  November 2006

Caring for Diabetic Patients With Cancer Receiving Steroids

Annette W. Kuck, RN, MS, CNP, AOCN®
Minneapolis, MN

Diabetes is a chronic illness characterized by impaired glucose metabolism, which results in hyperglycemia. Oncology care incorporates the use of glucocorticoids in multiple aspects of care. Prednisone is used for the treatment of non-Hodgkin lymphoma or for treatment of a severe cutaneous drug reaction. Dexamethasone can be administered as an antiemetic or for anaphylaxis prevention. The glucocorticoid category of drugs is known for causing hyperglycemia. This adverse reaction creates a unique challenge for patients with diabetes.

Epidemiology: Approximately 1 million people in the United States are known to have type I diabetes. The condition is an autoimmune disorder in which the body does not produce adequate amounts of endogenous insulin. Patients are managed with exogenous insulin, which can be adjusted according to blood glucose levels. An estimated 18.2 million people have Type II diabetes in the United States. Thirteen million of those individuals have a known diagnoses, but 5.2 million remain undiagnosed. Type II diabetics are more likely to be managed with oral hypoglycemic agents, which are not titrated according to blood glucose level. For both groups, the goal of treatment is to manage hyperglycemia and prevent long-term complications. Measurement of glycemic control is done with the hemoglobin A1C every two to three months. The American Diabetes Association target for blood glucose management is an A1C target of less than 7% and a fasting or preprandial glucose level of 90-130 mg/dl.

The challenge: Hyperglycemia is a known adverse side effect of dexamethasone and prednisone. It has been associated with immunosuppression, thrombosis, and increased size of ischemic infarct of cardiac and brain tissue. Dexamethasone also has been reported as producing the manifestations of latent diabetes mellitus. Normal glucose tolerance can be regained in healthy individuals. However, in patients with diabetes mellitus or impaired glucose tolerance, hyperglycemia can be prolonged and hyperosmolar nonketotic coma has been reported. Elevated blood glucose can be seen within 24 hours and is dose related. Patients who perform periodic testing of blood glucose and titration of insulin dose are better equipped to manage drug-related hyperglycemia. At greatest risk for long-term complications from steroid-induced hyperglycemia are patients managed by oral hypoglycemics, patients who remain undiagnosed, and patients who develop steroid-induced diabetes.

Meeting the challenge: All patients’ records should reflect that they have diabetes. In addition, education about glucocorticoids and hyperglycemia should be given to patients. The primary care provider or endocrinologist who is managing the diabetes pharmacologic treatment should be informed of the use of steroids so that medication adjustments can be made if necessary. Monitoring of the hemoglobin A1C should be performed every three months by either the medical oncologist or preferably the provider managing the diagnosis of diabetes.

The care of each patient needs to be individualized based on rationale for using steroids, the steroid used, and the type of diabetes. For example, a patient who is receiving a low emetogenic potential chemotherapy regimen may have their dexamethasone dose reduced or eliminated. Others may need to remain at the standard 20 mg dose of dexamethasone. Also, the frequency and dose of the glucocorticoid will affect the level of hyperglycemia. Patients who receive prednisone at high doses for several days will need longer treatment for hyperglycemia than those receiving dexamethasone every three to four weeks. The type of diabetes and patients’ treatments will affect patients’ ability to titrate medications. Type I patients are more accustomed to monitoring their blood glucose levels and adjusting their insulin doses. However, they may need additional education and short-acting insulin to maintain the desired blood glucose level. Type II diabetic patients may not have the ability to assess their own blood glucose level prior to treatment or at home. Based on the situation, some patients may need to be taught blood glucose monitoring and be put on intermittent, short-acting insulin for their steroid use. Monitoring of glucose levels will also help identify latent diabetes mellitus or steroid-induced diabetes.

Increased awareness of the challenges posed by steroid use in diabetic patients will lead to better monitoring and multidisciplinary collaboration. Additional research in inpatient and outpatient management of this population would help define evidence-based interventions and outcomes and lead to improved patient care and outcomes.

American Diabetes Association. (2006). Standard of medical care in diabetes. Diabetes Care, 29, 4–42.

Clement, S., Braithwaite, S.S., Magee, M.F., Ahmann, A., Smith, E.P., Schafer, R.G., et al. (2004). Management of diabetes and hyperglycemia in hospitals. Diabetes Care, 27, 553-591.

Daniel B.T. (2000). Glycemic crises in patients with hematologic malignancies. Critical Care Nursing Clinics of North America, 12, 297-339.

Diabetes Educational Forum. (n.d.). Epidemiology and disease pathology of type I diabetes. Glycemic targets. Epidemiology and disease pathology of type II diabetes. Retrieved August 18, 2006, from http://www.caringfordiabetes.com/E&P/Type1

Pandit, M. K., Burke, J., Gustafson, A.B., Minocha, A., & Peiris, A.N. (1993). Drug-induced disorders of glucose tolerance. Annals of Internal Medicine, 118, 529-539.

Back to SIG Newsletter front page

Special Interest Group Newsletter  November 2006

Featured ONS Podcast
Check Out a Podcast About the Doctorate of Nursing Practice

The Practice Doctorate in Nursing: Point/Counterpoint, by Laura Benson, RN, MSN, ANP, AOCN®, Ann O’Sullivan, Ph, CRNP, FAAN, Tukea Talber, RN, DNP, Marilyn Haas, PhD, RN, CNS, ANP-C

ONS Podcasts
ONS is proud to present a series of podcasts available for quick download or as a podcast subscription. ONS podcasts deliver the best content from our meetings and conferences to your own desktop. Learn about current advances in cancer treatment, get information on the latest hot topics in oncology nursing, and increase your clinical knowledge to improve your everyday practice and enhance the care of your patients with cancer.

Click here to access ONS Podcasts.

What is Podcasting?

Podcasting makes an audio file, typically an MP3 or MP4 file, available online for downloading via an automatic feed. You can then hear the podcast whenever you want from your own computer or a portable media player at your own convenience.

What equipment do I need to hear podcasts?

You can listen to podcast audio from your own computer (provided your computer has a sound card and can play MP3 audio files). If you want to make your podcasts portable, you will need to transfer them from your computer to a portable media device. If you want to subscribe to a podcast (so that you can automatically receive new podcasts when they are posted) you will need podcast subscription software. To manage your podcast subscriptions, your options include the latest free version of Apple's iTunes (which has the software built in), or other free services such as Odeo or iPodder.

Why should I subscribe to ONS Podcasts?
With an ONS podcast subscription, your software will do all the work for you. Instead of spending your time searching and downloading the files you want, you will be notified automatically when a new podcast becomes available, and the podcast will be downloaded to your computer. No guessing, no searching, and no work. To learn how to subscribe, see below.

How do I subscribe to a podcast?
To subscribe to ONS podcasts, simply click the button for your podcasting tool from the options available at the link above (orange podcast button). If you don't see a button for your preferred tool, simply highlight the URL in the box labeled "Manual RSS Link." Right-click this link (or Control-click in MacOS) and select "Copy" or "Copy Shortcut." You may then paste the link into your podcasting software. In iTunes you can find this option under the "Advanced" menu as "Subscribe to podcast."

Can I get CE Credit for listening to an ONS podcast?

Yes! CE credit is available for many of the podcast shows. Participants who listen to an entire CE podcast and complete the post-test and evaluation may earn contact hours. ONS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

When listening to a CE podcast, you will be given two passwords that will be identified at random times throughout the program. You are required to provide these passwords to access the evaluation to gain CE credit. To access the post-test and evaluation after listening to the podcast, visit the CE credit link located in the podcast description. You must achieve a 100% on the post-test to receive the CE certificate.
Back to SIG Newsletter front page

Special Interest Group Newsletter  November 2006

Do You Have Your National Provider Identifier?

Barbara Biedrzycki, AOCN®, CRNP
Abingdon, MD

You still have time, but why wait? Avoid the last-minute rush!

The Health Insurance Portability and Accountability Act (HIPAA) of 1996 contains a provision aimed at simplifying administrative processes by mandating healthcare providers to have a unique 10-digit number. This national provider identifier (NPI) number needs to be on all billing transactions, including Medicare, Medicaid, and private insurance companies, by May 23, 2007. The goal is to make the electronic transmission of health information more effective and efficient. Not only will all healthcare providers have unique numerical identifiers, but so will all health plans.

The NPI number replaces your Universal Physician Identification Number, individual health plan provider numbers, and any Medicare/Medicaid provider numbers you may have for billing, ordering and referring activities. However, it will not replace your tax identification number or social security number. You will keep this number for life, so starting memorizing it as soon as you get it.

Getting a NPI is not very difficult. First, check with your employer. They may already be applying for a NPI for you. If they haven’t already done so, you can do it yourself. Log onto the National Plan and Provider Enumeration System (NPPES) site at https://nppes.cms.hhs.gov, or you can call them at 800-465-3203. The application takes about 20 minutes to complete online.
Back to SIG Newsletter front page

Special Interest Group Newsletter  November 2006

Forum Discusses Special Interests of Oncology Nurse Practitioners

Barbara Biedrzycki, RN, MSN, AOCN®, CRNP
Abingdon, MD

At the American Academy of Nurse Practitioners (NPs) Annual Conference in Lake Grapevine, TX, a 90-minute oncology special interest forum was held. Although the open forum was moderated, the lively discussion addressed issues of interest to the attendees. Some of the issues discussed were the Oncology Nursing Certification Corporation's Advanced Oncology Certified Nurse Practitioner examination, whose responsibility is primary care during active oncology therapy, the doctorate of nursing practice (one participant was competing a doctorate of nursing practice program at Case Western University), and recommendations to improve the conference. According to the forum participants, the most important issues facing oncology NPs today are
  • True utilization of the NP role and standards of practice
  • Standards of practice across the states
  • Prescriptive authority and pain management
  • A scope of practice, Drug Enforcement Agency limitations for 72 hours for schedule II (may be Pennsylvania only)
  • Salary commiserates with experience
  • Improving independence in practice
  • Having very little support
  • Personally, preparing for the AOCNP; in general, reimbursement for our services
  • Job availability in rural areas
  • Being accepted as primary providers Low salaries
  • Recognition for the services we provide
  • More delineation of the oncology NP role.
Back to SIG Newsletter front page

Special Interest Group Newsletter  November 2006

New Look, Same Dedication
New ONS Logo Connects the Community of Oncology Nurses

The ONS logo has taken on a new and updated look, which was unveiled at the ONS 31st Annual Congress in Boston, MA. It represents not only where ONS is going but also where it has been. The colorful, contemporary design also includes a tagline that embodies the spirit of ONS: Where Oncology Nurses Connect. In 2005, a team of ONS staff members and an ONS member-at-large began the task of envisioning a new, modernized logo that remained true to the symbolism conveyed in the previous logo. After much creative brainstorming and collaboration with ONS members and leaders, the team developed the modern new image pictured here. The new logo depicts a polar area diagram, or coxcomb. Florence Nightingale used polar area diagrams in the 1850s to report statistics proving that fresh water and fruit along with sanitary methods reduced the mortality rate in injured soldiers. The team chose this symbol to reflect ONS's connectivity, inclusiveness, and community through the use of the pieces coming together in the center. The symbol also represents a stylized depiction of the light or flame from Nightingale's lamp. In essence, the new logo connects the past, present, and future of evidence-based nursing practice, a hallmark of ONS. Several products are available with the new ONS logo. Click here to view them or to place an order.
Back to SIG Newsletter front page


Special Interest Group Newsletter  November 2006

Order Your Free PEP Cards Today

ONS PEP (Putting Evidence Into Practice) Resource Cards provide the evidence base for oncology nursing interventions. They include common questions followed by interventions and recommendations for practice based on the level of evidence for each intervention. Order your free set today!
Back to SIG Newsletter front page

Special Interest Group Newsletter  November 2006

Articles of Interest
Nurse Practitioner SIG Members May Enjoy This Recently Published Article

Check out the Clinical Journal of Oncology Nursing for an interesting article that relates to oncology advanced practice nursing.

  • Carboplatin Hypersensitivity Reactions
  • by Debra Winkeljohn, RN, MSN, AOCN®, and Martha Polovich, MN, RN, AOCN® (CJON, Vol. 10, pp. 595-598)

    For access to the full-text versions of this and other CJON articles, visit the Publications area of the ONS Web site.
    Back to SIG Newsletter front page

    Special Interest Group Newsletter  November 2006

    Membership Information

    SIG Membership Benefits
    • Network with colleagues in an identified subspecialty area around the country.
    • Contribute articles for your SIG’s newsletter.
    • Participate in discussions with other SIG members.
    • Contribute to the future path of the SIG.
    • Share your expertise.
    • Support and/or mentor a colleague.
    • Receive information about the latest advancements in treatments, clinical
    • trials, etc.
    • Participate in ONS leadership by running for SIG coordinator-elect or join SIG work groups.
    • Acquire information with a click of a mouse at http://sig.vc.ons.org/, including
      • Educational opportunities for your subspecialty
      • Education material on practice
      • Calls to action
      • News impacting or affecting your specific SIG
      • Newsletters
      • Communiqués
      • Meeting minutes.
    Join a Virtual Community

    A great way to stay connected to your SIG is to join its Virtual Community. It’s easy to do so. All you will need to do is
    • Log on to the ONS Web site (www.ons.org).
    • Select "Membership" from the tabs above.
    • Then, click on "Chapters, SIGs & Virtual Communities."
    • Scroll down to "Special Interest Groups (SIG) Virtual Community" and click.
    • Now, select "Find a SIG."
    • Locate and click on the name of your SIG from the list of all ONS SIGs displayed.
    • Once the front page of your SIG's Virtual Community appears on screen, select "New User" from the top left. (This allows you to create log-in credentials.)
    • Type the required information into the text fields as prompted.
    • Click "Join Group" (at the bottom right of the text fields) when done.

      Special Notices

      • If you already have log-in credentials generated from the ONS Web site, use this information instead of attempting to generate new information.
      • If you created log-in credentials for the ONS Web site and wish to have different log-in information, you will not be able to use the same e-mail address to generate your new credentials. Instead, use an alternate e-mail address.
    Subscribe to Your SIG’s Virtual Community Discussion Forum

    All members are encouraged to participate in their SIG’s discussion forum. This area affords the opportunity for exchange of information between members and nonmembers on topics specific to all oncology subspecialties. Once you have your log-in credentials, you are ready to subscribe to your SIG’s Virtual Community discussion forum. To do so,
    • Select "Log In," located next to "New User," and enter your information.
    • Next, click on the "Discussion" tab on the top right of the title bar.
    • Now, select "Featured Discussion" from the left drop-down menu.
    • Locate and select "Subscribe to Discussion" inside the "Featured Discussion" section.
    • Go to "Subscription Options" and select "Options."
    • When you have selected and entered all required criteria, you will receive a confirmation message.
    • Click "Finish."
    • You are now ready to begin participating in your SIG’s discussion forum.
    Participate in Your SIG’s Virtual Community Discussion Forum
    • First, log in. (This allows others to identify you and enables you to receive notification [via e-mail] each time a response or new topic is posted.)
    • Click on "Discussion" from the top title bar.
    • Select "Featured Discussion" from the left drop-down menu.
    • Click on any posted topic to view contents and post responses.
    Sign Up to Receive Your SIG’s Virtual Community Announcements

    As an added feature, members also are able to register to receive their SIG’s announcements by e-mail.
    • From your SIG’s Virtual Community page, locate the "Sign Up Here to Receive Your SIG’s Announcements" section. This appears above the posted announcements section.
    • Select the "Click Here" feature, which will take you to a link to subscribe.
    • Once the "For Announcement Subscription Only" page appears on screen, select how you wish to receive your announcements.
      • As individual e-mails each time a new announcement is posted
      • One e-mail per day comprised of all new daily announcements posted
      • Opt-out, indicating that you will frequently browse your SIG’s Virtual Community page for new postings
    • Enter your e-mail address.
    • Click on "Next Page."
    • Because you have already joined your SIG’s Virtual Community, you will receive a security prompt with your registered user name already listed. Enter your password at this prompt and click "Finish."
    • This will bring up a listing of your SIG’s posted announcements. Click on "My SIG’s Page" to view all postings in their entirety or to conclude the registration process and begin browsing.
    Back to SIG Newsletter front page

    Special Interest Group Newsletter  November 2006

    Nurse Practitioner SIG Officers

    Coordinator (2005-2007)
    Wendy Vogel, RN, MSN, FNP, AOCN®
    Kingsport, TN

    Coordinator-Elect/Editor (2006-2007)
    Barbara Biedrzycki, RN, MSN, AOCN®, CRNP
    Abingdon, MD


    ONS Publishing Division Staff
    Elisa Becze, BA
    Copy Editor

    Know someone who would like to receive a print copy of this newsletter?
    To print a copy of this newsletter from your home or office computer, click here or on the printer icon located on the SIG Newsletter front page. Print copies of each online SIG newsletter also are available through the ONS National Office. To have a copy mailed to you or another SIG member, contact Membership/Leadership Administrative Assistant Carol DeMarco at cdemarco@ons.org or 866-257-4ONS, ext. 6230.

    To view past newsletters, click here.

    ONS Membership/Leadership Team Contact Information

    Angie Stengel, MS, CAE, Director of Membership/Leadership

    Diane Scheuring, MBA, Manager of Member Services

    Carol DeMarco, Membership/Leadership Administrative Assistant

    The Oncology Nursing Society (ONS) does not assume responsibility for the opinions expressed and information provided by authors or by Special Interest Groups (SIGs). Acceptance of advertising or corporate support does not indicate or imply endorsement of the company or its products by ONS or the SIG. Web sites listed in the SIG newsletters are provided for information only. Hosts are responsible for their own content and availability.

    Oncology Nursing Society
    125 Enterprise Dr.
    Pittsburgh, PA 15275-1214

    Back to SIG Newsletter front page